These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 34740043)

  • 1. The role of potassium in muscle membrane dysfunction in end-stage renal disease.
    Larsen LH; Z'Graggen WJ; Bostock H; Tan SV; Buus NH; Tankisi H
    Clin Neurophysiol; 2021 Dec; 132(12):3125-3135. PubMed ID: 34740043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Velocity recovery cycles of human muscle action potentials in chronic renal failure.
    Z'Graggen WJ; Aregger F; Farese S; Humm AM; Baumann C; Uehlinger DE; Bostock H
    Clin Neurophysiol; 2010 Jun; 121(6):874-81. PubMed ID: 20181515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Muscle velocity recovery cycles in myopathy.
    Meldgaard M; Kristensen RS; Z'Graggen WJ; Tan SV; Søndergaard K; Qerama E; Andersen H; Fuglsang-Frederiksen A; Tankisi H
    Clin Neurophysiol; 2023 Jul; 151():41-49. PubMed ID: 37148747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early detection of evolving critical illness myopathy with muscle velocity recovery cycles.
    Tankisi A; Pedersen TH; Bostock H; Z'Graggen WJ; Larsen LH; Meldgaard M; Elkmann T; Tankisi H
    Clin Neurophysiol; 2021 Jun; 132(6):1347-1357. PubMed ID: 33676846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Muscle velocity recovery cycles in neurogenic muscles.
    Witt A; Kristensen RS; Fuglsang-Frederiksen A; Pedersen TH; Finnerup NB; Kasch H; Tankisi H
    Clin Neurophysiol; 2019 Sep; 130(9):1520-1527. PubMed ID: 31295721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extrarenal potassium homeostasis with maximal exercise in end-stage renal disease.
    Clark BA; Shannon C; Brown RS; Gervino EV
    J Am Soc Nephrol; 1996 Aug; 7(8):1223-7. PubMed ID: 8866416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sarcolemmal depolarization in sporadic inclusion body myositis assessed with muscle velocity recovery cycles.
    Lee JH; Boland-Freitas R; Liang C; Ng K
    Clin Neurophysiol; 2019 Dec; 130(12):2272-2281. PubMed ID: 31542255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of deconditioning in the end-stage renal disease myopathy: physical exercise improves altered resting muscle oxygen consumption.
    Manfredini F; Lamberti N; Malagoni AM; Felisatti M; Zuccalà A; Torino C; Tripepi G; Catizone L; Mallamaci F; Zoccali C
    Am J Nephrol; 2015; 41(4-5):329-36. PubMed ID: 26067552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropathy, axonal Na+/K+ pump function and activity-dependent excitability changes in end-stage kidney disease.
    Krishnan AV; Phoon RK; Pussell BA; Charlesworth JA; Bostock H; Kiernan MC
    Clin Neurophysiol; 2006 May; 117(5):992-9. PubMed ID: 16516547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of blood lead concentration on the nerve conduction velocity in patients with end-stage renal disease.
    Kim YS; Park JH; Hong JR; Gil HW; Yang JO; Lee EY; Hong SY
    J Korean Med Sci; 2006 Apr; 21(2):290-4. PubMed ID: 16614516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uremic neuropathy: clinical features and new pathophysiological insights.
    Krishnan AV; Kiernan MC
    Muscle Nerve; 2007 Mar; 35(3):273-90. PubMed ID: 17195171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Muscle velocity recovery cycles: Comparison between surface and needle recordings.
    Z'graggen WJ; Trautmann JP; Boërio D; Bostock H
    Muscle Nerve; 2016 Feb; 53(2):205-8. PubMed ID: 26044702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum electrolyte concentrations and skeletal muscle excitability in vivo.
    Boland-Freitas R; Lee JH; Ng K
    Clin Neurophysiol; 2022 Mar; 135():13-21. PubMed ID: 35007839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered motor nerve excitability in end-stage kidney disease.
    Krishnan AV; Phoon RK; Pussell BA; Charlesworth JA; Bostock H; Kiernan MC
    Brain; 2005 Sep; 128(Pt 9):2164-74. PubMed ID: 15947058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Levels of L-carnitine in serum of patients with chronic renal failure treated by hemodialysis (HD)].
    Wanic-Kossowska M; Bombicki K; Kozioł L; Czarnecki R
    Pol Arch Med Wewn; 1998 Apr; 99(4):314-22. PubMed ID: 9760819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Muscle excitability testing.
    Tankisi H; Bostock H; Tan SV; Howells J; Ng K; Z'Graggen WJ
    Clin Neurophysiol; 2024 Aug; 164():1-18. PubMed ID: 38805900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Velocity recovery cycles of human muscle action potentials and their sensitivity to ischemia.
    Z'graggen WJ; Bostock H
    Muscle Nerve; 2009 May; 39(5):616-26. PubMed ID: 19229874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distal myopathy in nephropathic cystinosis.
    Vester U; Schubert M; Offner G; Brodehl J
    Pediatr Nephrol; 2000 Jan; 14(1):36-8. PubMed ID: 10654328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of intermittent high-frequency stimulation on muscle velocity recovery cycle recordings.
    Hochstrasser A; Rodriguez B; Söll N; Bostock H; Z'Graggen WJ
    J Neurophysiol; 2021 Sep; 126(3):736-742. PubMed ID: 34288792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional sympatholysis is impaired in end-stage renal disease.
    Sprick JD; Downey RM; Morison DL; Fonkoue IT; Li Y; DaCosta D; Rapista D; Park J
    Am J Physiol Regul Integr Comp Physiol; 2019 May; 316(5):R504-R511. PubMed ID: 30726117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.